Testosterone Aromatization to Estradiol in Course of Ovarian Functioning Brenner Tumor Associated With Endometrial Carcinoma and Endometriosis (Roncati-Manenti Triad)
Case report
OA: green
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study identified a rare triad of ovarian Brenner tumor, endometrial carcinoma, and endometriosis in postmenopausal women, finding high testosterone in the tumor and high estrogen/progesterone in the other tissues.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: Aromatization is the biochemical process in which aromatase catalyzes the conversion of testosterone into estradiol, the fundamental pathway for the synthesis of estrogens. When enhanced, it can lead to hyperestrogenism, a well-known risk factor for gynecological cancers.
METHODS: The surgical specimens, coming from 2 postmenopausal women with hyperestrogenism on pap smear and bioptic diagnosis of endometrial endometrioid carcinoma, were fixed in 10% neutral buffered formalin, paraffin embedded, and then submitted for routine hematoxylin/eosin staining and immunohistochemical characterization for antiestrogen, antiprogesterone, antitesterone, anti-MLH1, anti-PMS2, anti-MSH2, and anti-MSH6.
RESULTS: The presence of an undescribed triad represented by ovarian functioning Brenner tumor, endometrial carcinoma, and pelvic endometriosis has been ascertained. The immunohistochemical investigation proved a normal expression of the DNA mismatch repair proteins and revealed a bimodal hormonal status in the pathological tissues, that is, the Brenner tumor cells showed a high expression of testosterone, contrariwise endometrioid carcinoma and endometriosis a high estrogen and progesterone immunolabeling.
CONCLUSIONS: This synchronous triad underlines the importance of aromatization and hyperestrogenism in the development of gynecological malignancies in which the immunohistochemical detection of an active source of hormone production - to always keep in consideration during synchronous diseases - can guide subsequent antihormone chemotherapy based on aromatase inhibitors.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (18)
- W140092851 via openalex
- W185549381 via openalex
- W1975203448 via openalex
- W1976605645 via openalex
- W2018210095 via openalex
- W2023009163 via openalex
- W2049689871 via openalex
- W2069539467 via openalex
- W2094852647 via openalex
- W2126275169 via openalex
- W2134576998 via openalex
- W2290636298 via openalex
- W2317867663 via openalex
- W4249242318 via openalex
- W6605598703 via openalex
- W6696403611 via openalex
- W6698097258 via openalex
- W6716745507 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-10-21T06:16:17.486033+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:18:17.876363+00:00
License: CC0
· commercial use OK